TyraTech, Inc. Result of Special Meeting & Director Shareholdings (9036F)

TIDMTYR TIDMTYRU

RNS Number : 9036F

TyraTech, Inc.

16 November 2015

TyraTech, Inc

("TyraTech" or "the Company")

RESULT OF SPECIAL MEETING AND DIRECTORS' SHAREHOLDINGS

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM JAPAN, CANADA OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.

Further to the announcement dated 4 November 2015, TyraTech, Inc. (AIM:TYR and TYRU), a life sciences company focusing on nature-derived insect and parasite control products, is pleased to announce that at the Special Meeting held earlier today, each of the resolutions as set out in the notice of Special Meeting was duly passed. Accordingly, the Fundraise (as defined in the circular dated 4 November 2015) is now unconditional save for Admission.

Accordingly, the Company has approved, subject only to Admission, the issue of 105,333,333 new common shares in the capital of the Company of $0.001 each (the "New Common Shares") at 3 pence per share to the investors participating in the Fundraise.

Application has been made to the London Stock Exchange for the New Common Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission and the commencement of dealings will take place at 8 a.m. on 18 November 2015.

Following Admission, the Company will have 367,666,444 common shares of $0.001 each ("Common Shares") in issue, of which 1,084,413 will continue to be held in Treasury. Therefore, the total number of voting rights in the Company will be 366,582,031 ("Total Voting Rights"). The number of restricted Common Shares trading under TIDM 'TYR' following Admission will be 219,677,899 and the number of unrestricted Common Shares trading under TIDM 'TYRU' following Admission will be 147,988,545.

Furthermore, following Admission, there are changes to the following directors' holdings of Common Shares:

Alan Reade, who subscribed for 1,050,004 New Common Shares pursuant to the Subscription, is now interested in 13,783,620 Common Shares in the Company; representing an interest of 3.76% of the total voting rights of the Company.

Bruno Jactel, who subscribed for 435,733 New Common Shares pursuant to the Subscription, is now interested in 2,438,157 Common Shares in the Company; representing an interest of 0.67% of the total voting rights of the Company.

Barry Riley, who subscribed for 525,000 New Common Shares pursuant to the Subscription, is now interested in 3,723,413 Common Shares in the Company; representing an interest of 1.02% of the total voting rights of the Company.

James Hills, who subscribed for 539,200 New Common Shares pursuant to the Subscription, is now interested in 1,779,957 Common Shares in the Company representing an interest of 0.49% of the total voting rights of the Company.

For further information please contact:

 
TyraTech Inc. 
 Alan Reade, Non-Executive Chairman                  Tel: [phone] 
 Bruno Jactel, Chief Executive Officer               Tel: [phone] 
SPARK Advisory Partners Limited, Nominated Adviser 
 Matt Davis / Mark Brady                             Tel: [phone] 
Allenby Capital Limited, Joint Broker 
 Chris Crawford                                      Tel: [phone] 
Whitman Howard Limited, Joint Broker 
 Ranald Mc-Gregor Smith / Niall Devins               Tel: [phone] 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFERLDLRLIE

(END) Dow Jones Newswires

November 16, 2015 12:01 ET (17:01 GMT)